Technology stocks, specifically the Magnificent Seven, powered the S&P 500 higher over the past three years. And though investors rotated out of some of these […]
On May 15, 2026, HarbourVest Partners disclosed a new position in Generate Biomedicines (NASDAQ:GENB), acquiring 1,722,210 shares in the first quarter. The estimated transaction value […]